Ignite Creation Date:
2024-05-06 @ 11:13 AM
Last Modification Date:
2024-10-26 @ 12:42 PM
Study NCT ID:
NCT03463733
Status:
UNKNOWN
Last Update Posted:
2020-10-08
First Post:
2018-03-01
Brief Title:
Hydroxy-urea and Temozolomide in Patients With a Recurrent Malignant Brain Tumor Glioblastoma
Sponsor:
ME van Linde
Organization:
Amsterdam UMC location VUmc
Organization Data
Organization:
Amsterdam UMC location VUmc
Class:
OTHER
Study ID:
Pro-1611
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
ME van Linde
Lead Sponsor Class:
OTHER
Responsible Party:
ME van Linde
Responsible Party Title:
MD Principal Investigator
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Amsterdam UMC location VUmc
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Massachusetts General Hospital | OTHER |